n°160 | March 28, 2022
In this issue:

New US evidence that PSA testing works

Study shows that stopping screening increases cases of metastatic cancer
24 Mar 2022

New event will explore key messages on active surveillance

Europa Uomo’s fourth seminar open to all
21 Mar 2022

Your thoughts on communication are required

New survey from major big data prostate cancer study
7 Mar 2022

Europe's scientists back prostate screening

Final reports from influential bodies say organised PSA testing makes sense
3 Mar 2022

Europa Uomo's 'deep concern' for Ukraine

Thoughts lie with those receiving cancer treatments
2 Mar 2022
Prostate Research and Treatments

New EAU Guidelines on Prostate Cancer 2022

The Prostate Cancer (PCa) Guidelines Panel of the EAU have prepared this guidelines document to assist medical professionals in the evidence-based management of PCa.

Our own vice chairman, Erik Briers, is a member of that PCa Guidelines Panel.

Read the new guidelines here.

Artificial intelligence for diagnosis and Gleason grading of prostate cancer

Wouter Bulten, from the Radboud University Medical Center, Nijmegen, the Netherlands, and coauthors reported the outcomes of the international PANDA histopathology competition, in which 1,290 deep learning algorithm developers were challenged to come up with reproducible algorithms that could match the findings of human experts.

At least one AI product for detecting prostate cancer – the Paige Prostate system – has already been approved for clinical use in the United States. The Food and Drug Administration authorized marketing it in September 2021, as an adjunct to – but not replacement for – pathologist review.

These algorithms correctly detected tumors in 99.7% of cases, and correctly identified 92.9% of negative results.


Read the article at: https://www.nature.com/articles/s41591-021-01620-2


Europa Uomo

Tell us your prostate cancer story

For our ‘Voices‘ section on the Europa Uomo website, we are looking for your prostate cancer journey to inform fellow prostate patients.

If you are interested to put your prostate cancer story on paper (max. 500 words), please contact our communication advisor Simon Crompton (mail@simoncrompton.com) first to decide which areas you should concentrate on.

Thank you in advance.

What is the role of the patient in the management of prostate cancer?

On the 2nd day of the 9th Belgian Multidisciplinary Meeting on Urological Cancers (BMUC), our chairman André Deschamps gave a presentation ‘What is the role of the patient in the management of prostate cancer?’.

You can watch the recorded presentation here. Select on ‘BMUC – day 2’, part 3 and watch the recording of the presentation of our chairman.

Items of Interest

Webinar "Your Voice in the Future of Active Surveillance"

Do you want to see where active surveillance is heading? Do you have some views you want to share?

Active Surveillance Patients International and the AnCan Virtual Support Group for Active Surveillance and other leading advocates and doctors are holding a webinar, “Your Voice in the Future of Active Surveillance,”  on April 22 at 11 a.m.Eastern/4 p.m. GMT/5 p.m. CET on this topic.

Sign up here ASAP: https://zoom.us/meeting/register/tJEtfuuqrzwtHNPuqzkigx65YBk8vV-teUdy

Read the flyer here.


All previous issues are available on website: www.europa-uomo.org/newsletters/